Table 7.
Risk of death from invasive lobular carcinoma grade 2 and invasive ductal carcinoma grade 2 according to E-cadherin status
| Number of cases | Deaths from breast cancer | HR 95% CI |
HR 95% CI |
HR 95% CI |
HR 95% CI |
|||||
|---|---|---|---|---|---|---|---|---|---|---|
| Unadjusted | Adjusted for age | Adjusted for stage | Adjusted for time period of diagnosis (10-year intervals) | |||||||
| Ductal, E-cad+ | 260 | 94 | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| Ductal, E-cad− | 46 | 16 | 1.03 | 0.61–1.75 | 1.00 | 0.59–1.71 | 1.17 | 0.68–2.00 | 1.03 | 0.60–1.76 |
| Lobular, E-cad+ | 24 | 7 | 0.84 | 0.39–1.81 | 0.86 | 0.40–1.88 | 0.87 | 0.40–1.89 | 0.83 | 0.38–1.79 |
| Lobular, E-cad− | 74 | 35 | 1.96 | 1.32–2.89 | 1.88 | 1.27–2.80 | 2.30 | 1.54–3.44 | 2.03 | 1.36–3.01 |
| 404 | 152 | |||||||||
HR, hazard ratio; CI, confidence interval.